Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
- Resource Type
- Article
- Source
- Chinese Medical Journal (LWW); September 2021, Vol. 134 Issue: 18 p2243-2245, 3p
- Subject
- Language
- ISSN
- 03666999; 25425641